Skip to main content

Take the fast track to becoming a V3 and V3+ expert

Premal Kamdar CRS RIA Quote

Early detection of Cytokine Release Syndrome (CRS) using digital health products and predictive algorithms will enable us to maximize the potential of cell therapies and T-cell engagers.

The collaboration with DATAcc by DiMe has been instrumental in supporting the industry towards this objective. I am optimistic about a future where more patients will have access to and benefit from these transformative therapies.”

– Premal Kamdar | Director, Digital Health Product Management, Bristol Myers Squibb